Ozempic, the brand name drug for a medication called semaglutide, is one of the most popular drugs on the market right now. Originally developed to treat type 2 diabetes, the injectable drug has recently boomed in popularity for its off-label use to help people lose weight... fast. Celebrities and public figures have admitted they're taking it. Instagram influencers are showing off remarkable before and after photos. It's been called "TikTok's favorite weight loss drug." As one doctor said, "we haven't seen a prescription drug with this much cocktail and dinner chatter since Viagra came to the market."But alongside the rise in Ozempic prescriptions come many questions still unknown: Who should be taking it? Is it safe for longterm use? Who is it safe for? Should children be prescribed it to treat childhood obesity, as the American Academy of Pediatrics recently advised? Is Ozempic a permanent solution to the obesity epidemic? Or is it more like a bandaid, a quick fix that does little to address the root causes of obesity? And, to that end, what is the root cause of obesity? Is it a "brain disease," as one Harvard doctor recently declared on 60 Minutes that warrants medication? Or do diet, exercise, willpower and other behavioral lifestyle choices still matter?These are questions that my guests do not agree on. Dr. Chika Anekwe is an obesity medicine physician at Massachusetts General Hospital and an instructor in medicine at Harvard Medical School. Dr. Vinay Prasad is a hematologist-oncologist and a professor at the University of California San Francisco. His most recent book is Malignant: How Bad Policy and Bad Evidence Harm People with Cancer. And Calley Means is a former consultant for food and Pharma companies who now works to expose their practices and instead incentive healthy food as the foundation of health policy.Today, Dr. Anekwe, Dr. Prasad, and Means debate: will Ozempic solve obesity in America? Learn more about your ad choices. Visit megaphone.fm/adchoices

Epidemiologist Vinay Prasad discusses the mistakes made in implementing the Covid vaccine, costs of these mistakes, and how to improve next time. Topics include vaccine platforms, school closures' impacts, ethical challenges in trials, political influence on mask-wearing, analyzing vaccine side effects study, and navigating medical decision-making.

Oncologist and epidemiologist Vinay Prasad argues that too many very expensive drugs get approved by the FDA that have very limited impact on the lives of patients. Prasad explains the incentives that distort the current system. The general problem, he explains to EconTalk host Russ Roberts, is the death of duty--too many players in the health care landscape and elsewhere stay quiet or do the wrong thing in order to serve themselves.

Join Dr. Casey Means, a health advocate and author, and Dr. Vinay Prasad, a prominent physician, as they dive into hot-button issues surrounding women's spaces and health policy. They discuss Rep. Nancy Mace's efforts to protect women's restrooms for biological women, highlighting privacy and safety concerns. Vinay shares insights on COVID vaccine risks, particularly myocarditis. Meanwhile, Casey explores RFK Jr.'s ambitious plans to reform health agencies, and both guests dissect the intricate ties between corporate interests and public health crises.

Dr. Vinay Prasad and Vivek discuss FDA impact on healthcare, drug pricing, and innovative solutions. They dive into COVID policy debates, unintended consequences of regulations, and the need for diverse viewpoints in academic medicine.

Oncologist and epidemiologist Vinay Prasad discusses the complexities of cancer screening, exploring the limitations of current tests and the controversy surrounding mammography. The podcast also delves into the dilemmas of medical treatment for the elderly and emphasizes the importance of informed discussions and larger studies in settling debates on screening test efficacy.

Vinay Prasad, a hematologist-oncologist and Professor, discusses the impact of mask mandates and lockdowns, stifling of dissenting views among doctors and scientists, and improving readiness for the next pandemic. Topics include critiquing COVID policy, messaging to extraterrestrial intelligence, reevaluating COVID-19 response policies, analyzing COVID-19 policies and media response, controversy surrounding COVID-19 vaccine mandates, and lack of studies on COVID-19 measures.

Vinay Prasad, a hematologist-oncologist and professor at UC San Francisco, delves into Robert F. Kennedy Jr.'s controversial health proposals. They discuss the implications of Kennedy's ideas on public health, including fluoride, food additives, and vaccine skepticism. Prasad critically evaluates the balance between individual rights and corporate influence in health policies. The conversation also highlights systemic issues in American healthcare and the need for accountability and innovation within drug regulation.

Vinay Prasad, a hematologist and public health commentator, dives into Robert F. Kennedy Jr.'s potential impact on America's healthcare system. He discusses how RFK Jr.'s controversial views could challenge Big Pharma's grip on policy. Prasad evaluates Kennedy's proposed reforms through a European lens, comparing healthcare practices and addressing misconceptions about European models. The podcast also examines corporate lobbying and the necessity for independent healthcare recommendations, highlighting calls for change amidst a flawed system.

The podcast discusses Dr. Vinay Prasad's contrarian views on COVID-19, demanding randomized trials for ICU patient care. It explores misinformation spread by influential figures and the normalization of anti-vaccine sentiments. The controversy surrounding randomized controlled trials and the disparities in research on pharmaceuticals and non-pharmacologic interventions are also highlighted. The Great Barrington Declaration and differing perspectives on COVID-19 management strategies are analyzed, emphasizing the importance of critical thinking.